---
figid: PMC7299722__JCMM-24-6534-g001
figtitle: Effects of doxorubicin on cardiac mitochondrial dynamics and mitochondrial
  function
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- Adenoviridae
- Bellapiscis medius
pmcid: PMC7299722
filename: JCMM-24-6534-g001.jpg
figlink: pmc/articles/PMC7299722/figure/jcmm15305-fig-0001/
number: F1
caption: The effects of doxorubicin on cardiac mitochondrial dynamics and mitochondrial
  function. Doxorubicin inhibits mitochondrial fusion proteins (MFN1, MFN2 and OPA1)
  and promotes mitochondrial fission by increasing DRP1 phosphorylation. Doxorubicin
  undergoes redox cycling and generation of ROS. ROS, in turn, induces lipid peroxidation
  at cellular membrane and targets subcellular organelle causing mitochondrial DNA
  damage and decreases mitochondrial transmembrane potential. Doxorubicin inhibits
  electron transport chain proteins subunit I, II, IV and induces mPTP opening which
  initiates apoptotic signalling pathway. In addition, doxorubicin binds to topoisomerase
  IIβ in the nucleus causing DNA double‐stranded breaks and induces apoptosis. Dox,
  Doxorubicin; MDA, Malondialdehyde; mPTP, mitochondrial permeability transition pore;
  mtDNA, Mitochondrial DNA; ROS, Reactive oxygen species; ΔΨm, Mitochondrial transmembrane
  potential
papertitle: 'Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial
  dynamics and mitochondrial function: Insights for future interventions.'
reftext: Nichanan Osataphan, et al. J Cell Mol Med. 2020 Jun;24(12):6534-6557.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9418841
figid_alias: PMC7299722__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
redirect_from: /figures/PMC7299722__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7299722__JCMM-24-6534-g001.html
  '@type': Dataset
  description: The effects of doxorubicin on cardiac mitochondrial dynamics and mitochondrial
    function. Doxorubicin inhibits mitochondrial fusion proteins (MFN1, MFN2 and OPA1)
    and promotes mitochondrial fission by increasing DRP1 phosphorylation. Doxorubicin
    undergoes redox cycling and generation of ROS. ROS, in turn, induces lipid peroxidation
    at cellular membrane and targets subcellular organelle causing mitochondrial DNA
    damage and decreases mitochondrial transmembrane potential. Doxorubicin inhibits
    electron transport chain proteins subunit I, II, IV and induces mPTP opening which
    initiates apoptotic signalling pathway. In addition, doxorubicin binds to topoisomerase
    IIβ in the nucleus causing DNA double‐stranded breaks and induces apoptosis. Dox,
    Doxorubicin; MDA, Malondialdehyde; mPTP, mitochondrial permeability transition
    pore; mtDNA, Mitochondrial DNA; ROS, Reactive oxygen species; ΔΨm, Mitochondrial
    transmembrane potential
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Decr1
  - Crmp1
  - Dnm1l
  - Mfn2
  - Fis1
  - Fvis1
  - Opa1
  - Med12
  - Trp53
  - Casp3
  - DECR1
  - CRMP1
  - UTRN
  - DENR
  - DNM1L
  - DAPK2
  - MFN2
  - FIS1
  - TOP2B
  - OPA1
  - MED12
  - TP53
  - TP63
  - TP73
  - Utrn
  - Tp53
---
